KBP Biosciences

KBP is a clinical-stage biotech pioneer dedicated to developing innovative drugs for patients worldwide with unmet medical needs. Its innovative drug development mindset, proprietary medicinal chemistry expertise, and extensive clinical development and regulatory proficiency enable this pioneer to discover novel "New Chemical Entities" (NCEs) targeting validated pathways, bringing new hope to patients suffering from cardio-renal diseases, infectious diseases, respiratory conditions, inflammation, and autoimmune disorders.